XML 18 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Total revenue, net $ 10,698 $ 14,774
Costs and operating expenses:    
Cost of product revenue 1,262 1,326
Research and development 42,857 20,735
Selling and marketing 14,148 10,183
General and administrative 16,348 14,147
Total costs and operating expenses 74,615 46,391
Loss from operations (63,917) (31,617)
Other income (expense):    
Interest income 3,826 3,922
Interest expense (2,984) (4,051)
Change in fair value of derivative liabilities (978) (5,152)
Loss on extinguishment of debt   (27,950)
Total other expense, net (136) (33,231)
Net loss $ (64,053) $ (64,848)
Net loss per share, basic (in dollars per share) $ (0.38) $ (0.49)
Weighted average common shares outstanding, basic (in shares) 169,396,989 132,021,945
Net loss per share, diluted (in dollars per share) $ (0.38) $ (0.49)
Weighted average common shares outstanding, diluted (in shares) 169,396,989 132,021,945
Product revenue, net    
Revenue:    
Total revenue, net $ 10,634 $ 14,715
Collaboration revenue    
Revenue:    
Total revenue, net $ 64 $ 59